Skip to main content

Abbott Labs’ stock rises as third-quarter results beat estimates despite plunging COVID sales

Strong medical device sales boost results even as investors fear obesity drugs' impact.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.